Page last updated: 2024-09-03

tafenoquine and Deficiency of Glucose-6-Phosphate Dehydrogenase

tafenoquine has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (53.85)	24.3611
2020's	6 (46.15)	2.80

Authors

Authors	Studies
Commons, RJ; McCarthy, JS; Price, RN	1
Derbyshire, ER; Lu, KY	1
Devine, A; Dittrich, S; Howes, RE; Ley, B; Moore, KA; Price, DJ; Price, RN; Simpson, JA	1
Sayers, DR; Webber, BJ	1
Fernando, D; Rajapakse, S; Rodrigo, C	1
Chu, CS; Hwang, J	1
Bancone, G; Chu, CS; Jittamala, P; Taylor, WRJ; Watson, J; White, NJ	1
Bancone, G; Bansil, P; Chu, CS; Domingo, GJ; Gornsawun, G; Nosten, F; Pal, S; Porn, P	1
Angus, B; Aruachan, S; Bancone, G; Breton, JJ; Brito, MAM; Casapía, M; Chu, CS; Chuquiyauri, R; Clover, DD; Costa, MRF; Craig, G; Duparc, S; Green, JA; Hardaker, E; Hien, TT; Jones, SW; Kendall, L; Koh, GCKW; Lacerda, MVG; Llanos-Cuentas, A; Mohamed, K; Monteiro, WM; Namaik-Larp, C; Nguyen, CH; Nosten, FH; Papwijitsil, R; Rousell, VM; Val, F; Vélez, ID; Villegas, MF; Wilches, VM	1
Berman, JD	1
Chu, CS; Freedman, DO	1
Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA	1
Fernando, SD; Rajapakse, S; Rodrigo, C	1

Reviews

4 review(s) available for tafenoquine and Deficiency of Glucose-6-Phosphate Dehydrogenase

Article	Year
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. The Cochrane database of systematic reviews, 2020, 09-06, Volume: 9 Topics: Adult; Aminoquinolines; Antimalarials; Chloroquine; Drug Administration Schedule; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Parasitemia; Placebos; Primaquine; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention	2020
Tafenoquine: a toxicity overview. Expert opinion on drug safety, 2021, Volume: 20, Issue:3 Topics: Adult; Aminoquinolines; Animals; Antimalarials; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Mental Disorders	2021
Tafenoquine and G6PD: a primer for clinicians. Journal of travel medicine, 2019, Jun-01, Volume: 26, Issue:4 Topics: Aminoquinolines; Antimalarials; Contraindications, Drug; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Malaria; Randomized Controlled Trials as Topic; Recurrence	2019
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. The Cochrane database of systematic reviews, 2015, Apr-29, Issue:4 Topics: Adult; Aminoquinolines; Antimalarials; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Primaquine; Primary Prevention; Randomized Controlled Trials as Topic; Recurrence	2015

Trials

1 trial(s) available for tafenoquine and Deficiency of Glucose-6-Phosphate Dehydrogenase

Article	Year
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria. The New England journal of medicine, 2019, 01-17, Volume: 380, Issue:3 Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Chloroquine; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Kaplan-Meier Estimate; Malaria, Vivax; Male; Parasitemia; Plasmodium vivax; Primaquine; Prospective Studies; Secondary Prevention	2019

Article

Year

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

The New England journal of medicine, 2019, 01-17, Volume: 380, Issue:3

Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Chloroquine; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Kaplan-Meier Estimate; Malaria, Vivax; Male; Parasitemia; Plasmodium vivax; Primaquine; Prospective Studies; Secondary Prevention

2019

Other Studies

8 other study(ies) available for tafenoquine and Deficiency of Glucose-6-Phosphate Dehydrogenase

Article	Year
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. The Medical journal of Australia, 2020, Volume: 212, Issue:4 Topics: Aminoquinolines; Antimalarials; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria; Male; Practice Guidelines as Topic; Primaquine	2020
Tafenoquine: A Step toward Malaria Elimination. Biochemistry, 2020, 03-03, Volume: 59, Issue:8 Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Cytochrome P-450 CYP2D6; Gene Knockdown Techniques; Glucosephosphate Dehydrogenase Deficiency; Haplorhini; Humans; Malaria, Vivax; Methemoglobinemia; Mice; Plasmodium cynomolgi; Plasmodium vivax; Zebrafish	2020
Cost-Effectiveness Analysis of Sex-Stratified The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:1 Topics: Adult; Afghanistan; Aminoquinolines; Anemia, Hemolytic; Antimalarials; Chloroquine; Cost-Benefit Analysis; Ethiopia; Female; Glucosephosphate Dehydrogenase Deficiency; Hemizygote; Heterozygote; Homozygote; Humans; Indonesia; Malaria, Vivax; Male; Mass Screening; Medication Adherence; Plasmodium vivax; Primaquine; Quality-Adjusted Life Years; Recurrence; Sex Factors; Vietnam	2020
Letter to the editor: G6PD deficiency in the Tafenoquine era. MSMR, 2020, Volume: 27, Issue:6 Topics: Aminoquinolines; Antimalarials; Contraindications, Drug; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Vivax; Male; Mass Screening; Military Personnel; Plasmodium vivax; Population Surveillance; Prevalence; United States	2020
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Female; Glucosephosphate Dehydrogenase Deficiency; Heterozygote; Humans; Lactation; Malaria, Vivax; Male; Plasmodium vivax; Pregnancy; Primaquine; Young Adult	2018
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood. PloS one, 2018, Volume: 13, Issue:5 Topics: Adult; Aminoquinolines; Antimalarials; Area Under Curve; Biosensing Techniques; Clinical Enzyme Tests; Endemic Diseases; Ethnicity; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobinometry; Humans; Malaria, Vivax; Male; Methemoglobinemia; Myanmar; Point-of-Care Systems; Pregnancy; Pregnancy Complications, Hematologic; Primaquine; ROC Curve; Spectrophotometry, Ultraviolet	2018
Approval of Tafenoquine for Malaria Chemoprophylaxis. The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:6 Topics: Aminoquinolines; Antimalarials; Australia; Chemoprevention; Child; Contraindications, Drug; Drug Administration Schedule; Drug Approval; Female; Fetus; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Methemoglobin; Pregnancy; Psychotic Disorders; United States	2019
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity. Proceedings of the National Academy of Sciences of the United States of America, 2013, Oct-22, Volume: 110, Issue:43 Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous	2013